Correlation between vitamin D receptor polymorphism with clinical and nutritional status in intensive phase treatment of pulmonary tuberculosis

Irawaty Djaharuddin (Makassar, Indonesia), Irawaty Djaharuddin

Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Session: Active and latent tuberculosis: biomarkers
Session type: Poster Discussion
Number: 2117
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Irawaty Djaharuddin (Makassar, Indonesia), Irawaty Djaharuddin. Correlation between vitamin D receptor polymorphism with clinical and nutritional status in intensive phase treatment of pulmonary tuberculosis. Eur Respir J 2016; 48: Suppl. 60, 2117

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Are we effectively monitoring and treating vitamin D deficient patients with tuberculosis?
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013

Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019


Vitamin D levels in patients with a clinical diagnosis of tuberculosis
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013


Effect of anti-tuberculosis treatment on body composition during the intensive phase
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016


Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 455s
Year: 2005

Cholecalciferol supplementation in patients taking anti tuberculosis treatment
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Improvement of the treatment protocol for newly diagnosed pulmonary tuberculosis, depending on the glutathione-S-transferase gene polymorphism
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Impact of diabetes on the presenting features of tuberculosis patients
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Outcome of vitamin A & zinc supplementation in the treatment of smear positive pulmonary tuberculosis patients
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Vitamin C levels in Indian patients with active pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010


Investigation of vitamin D receptor gene variants in Iranian patients affected with pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005

Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016


Evaluation of vitamin D replacement in the tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012


Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Effect of vitamin A & zinc supplementation on clinical response &nutritional status in patients with tuberculosis getting standard chemotherapy: a double blind, placebo control study in Bangladesh
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004

Vitamin D levels and risk of infection, assessment for disease severity, and predictor of mortality in the Chinese intensive care units: A prospective cohort study
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Profile of serum vitamin D levels in stable COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


Link between clinical severity of osteoarticular tuberculosis and the combined presence of pulmonary tuberculosis
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016